8-K: Moderna Amends Bylaws, Holds Annual Meeting

Moderna, Inc. announced amendments to its bylaws establishing federal district courts as the exclusive forum for securities-related lawsuits and reported results from its 2026 Annual Meeting of Stockholders.

Summary

• Moderna, Inc. has amended its Second Amended and Restated By-Laws to designate U.S. federal district courts as the exclusive venue for all complaints arising under the Securities Act of 1933, unless the company agrees otherwise.
• This by-law amendment is effective immediately and is a response to recent changes in Delaware corporate law.
• The company held its 2026 Annual Meeting of Stockholders on May 6, 2026.
• Stockholders elected directors, approved executive compensation on an advisory basis, and voted to hold future advisory votes on executive compensation annually.
• Ernst & Young LLP was ratified as the company's independent registered public accounting firm for the year ending December 31, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, primarily consisting of routine corporate governance updates and annual meeting results, with no significant new financial information or strategic shifts.

Positives

• The election of directors was successful, with a significant majority of votes in favor for each nominee.
• Stockholders approved, on a non-binding advisory basis, the compensation of the company's named executive officers.
• The company will hold future advisory votes on executive compensation annually, aligning with stockholder preference.
• The appointment of Ernst & Young LLP as the independent registered public accounting firm was ratified with strong support.

Negatives

• A notable portion of votes were cast against the compensation of named executive officers (90,761,924 votes against).
• There were a significant number of broker non-votes on the executive compensation proposal (41,911,864).

Risks

• The by-law amendment could potentially limit stockholder options for pursuing securities-related litigation, although it aims to provide a consistent forum.
• The significant opposition to executive compensation, while advisory, may indicate dissatisfaction among some stockholders.

Future Outlook

The filing does not contain specific forward-looking financial guidance. However, the company has established a clear process for future advisory votes on executive compensation, which will occur annually.

Management Comments

• The Board approved the By-Law Amendment in response to recent amendments to the General Corporation Law of the State of Delaware regarding such forum selection provisions.
• After considering the voting results for the frequency of future advisory votes on compensation, the Company has determined that it will hold future advisory, non-binding votes on the compensation of our named executive officers on an annual basis.

Industry Context

StockSavvy.ai notes that the by-law amendment regarding forum selection for securities litigation is a trend observed across many public companies, particularly those incorporated in Delaware, as a response to evolving corporate law and efforts to streamline litigation.

Corporate Governance

Legal Proceedings

• The by-law amendment establishes federal district courts as the exclusive forum for Securities Act of 1933 claims, unless the company consents otherwise.

Stakeholder Impact

• Shareholders: The by-law amendment may affect how shareholders pursue claims under the Securities Act of 1933. The annual advisory vote on executive compensation provides a continued avenue for shareholder input on management pay.
• Management: The forum selection by-law may impact the legal landscape for executive officers concerning securities-related litigation.
• Legal Counsel: Will need to adhere to the new forum selection by-law for any future securities litigation involving the company.

Next Steps

• Future advisory votes on executive compensation will be held annually.
• The by-law amendment is effective immediately and will govern future securities litigation.
• Elected directors will serve until the 2029 Annual Meeting of Stockholders.

Key Dates

Keywords

Moderna, 8-K, Bylaws, Annual Meeting, Stockholders, Securities Act, Forum Selection, Executive Compensation